Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Duodenal perforation and retroperitoneal abscess after coil embolisation of an inferior pancreaticoduodenal artery pseudoaneurysm in a patient previously treated with bevacizumab.

Created on 30 Sep 2026

Authors

Haruka Nakashima, Makoto Okawaki, Takashi Adachi, Takeshi Nagasaka

Published in

BMJ case reports. Volume 19. Issue 9. Sep 29, 2026. Epub Sep 29, 2026.

Abstract

Transcatheter arterial embolisation is an established treatment for visceral pseudoaneurysms and pancreaticoduodenal arcade embolisation is generally well tolerated because of rich collateral flow. We report a man in his 70s with metastatic rectal cancer previously treated with bevacizumab who developed duodenal perforation and retroperitoneal abscess 15 days after embolisation of an inferior pancreaticoduodenal artery pseudoaneurysm using coils and adjunctive N-butyl cyanoacrylate-Lipiodol. He improved with broad-spectrum antibiotics, CT-guided drainage and conservative management, avoiding emergency surgery. The course is compatible with a multifactorial process in which procedure-related local ischaemic stress, altered collateral reserve, prior surgical alteration of regional vessels and impaired tissue repair after prior bevacizumab and recent fruquintinib exposure may have contributed. Pancreatic inflammation or leakage was not confirmed but remains a possible alternative or interacting mechanism. Causality cannot be established from a single case.

PMID:
42810750
Bibliographic data and abstract were imported from PubMed on 30 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement